Finance

Beta
Lists
2526:HKG
Hangzhou Diagens Biotechnology Co Ltd
HK$309.80
+0.85%
(+2.60) 1D
Jun 30, 4:08:05 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2526...
Open
HK$312.00
High
HK$315.60
Low
HK$305.00
Mkt. cap
27.53B
Avg. vol.
87.86K
Volume
70.10K
52-wk high
HK$428.00
52-wk low
HK$178.00
EPS
-HK$0.87
Shares outstanding
88.88M
No. of employees
166
Open
HK$312.00
High
HK$315.60
Low
HK$305.00
Mkt. cap
27.53B
Avg. vol.
87.86K
Volume
70.10K
52-wk high
HK$428.00
52-wk low
HK$178.00
EPS
-HK$0.87
Shares outstanding
88.88M
No. of employees
166
News stories
From sources across the web
About Hangzhou Diagens Biotechnology Co Ltd
CEO-
Employees166
Founded2016
Headquarters-
SectorMedical device
Websitediagens.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Dec 2024
Dec 2025
Revenue
50.76M
52.81M
Cost of goods sold
13.10M
19.39M
Cost of revenue
13.10M
19.39M
Research and development expenses
11.12M
35.68M
Total research and development expenses
-
-
Selling, general, and admin expenses
14.72M
25.14M
Operating expense
27.61M
64.28M
Total operating expenses
40.71M
83.67M
Operating income
10.05M
-30.87M
Other non operating income
-5.99M
-11.35M
EBT including unusual items
7.45M
-30.47M
EBT excluding unusual items
-1.07M
-42.20M
Income tax expense
15.00K
15.00K
Effective tax rate
0.20%
-0.05%
Other operating expenses
1.76M
3.47M
Net income
7.44M
-30.49M
Net profit margin
14.65%
-57.73%
Earnings per share
-
-
Interest and investment income
215.00K
102.00K
Interest expense
-5.41M
-84.00K
Net interest expenses
-5.19M
18.00K
Depreciation and amortization charges
-
-
EBITDA
12.92M
-29.23M
Gain or loss from assets sale
2.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer